🇺🇸 PTGX — Protagonist Therapeutics, Inc.
Salud Compra fuertePrecio actual
140,24 USD
Máx. histórico
158,62
78 días
Caída desde máximo
-11,59%
Rango 52 semanas
75,44 – 160,81
Variación hoy
+0,62%
Cierre anterior
139,37
Rango de hoy
139,91 – 144,27
Volumen hoy
673.087
Peor caída histórica
-85,79%
01/09/2021 → 13/06/2022
Recuperado en 1001 días
Volatilidad anualizada ⓘ
89,34%
- Nombre completo
- Protagonist Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 141
- PER ⓘ
- 136,16 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 178,57 USD (puede no estar actualizado)
- Primera cotización
- 11/08/2016
- Precio actualizado
- hace 12 horas
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/08/2018 | 10,12 | 11,52 | 10,11 | 10,92 | -0,64% | 13,93% | 477.300 |
| 07/08/2018 | 10,49 | 11,90 | 10,03 | 10,99 | -1,17% | 17,83% | 1.753.400 |
| 06/08/2018 | 7,61 | 11,50 | 7,60 | 11,12 | +58,63% | 51,25% | 5.200.100 |
| 03/08/2018 | 6,96 | 7,06 | 6,81 | 7,01 | +0,43% | 3,59% | 94.300 |
| 02/08/2018 | 7,01 | 7,50 | 6,86 | 6,98 | -0,57% | 9,13% | 50.600 |
| 01/08/2018 | 6,94 | 7,22 | 6,83 | 7,02 | +1,45% | 5,62% | 92.200 |
| 31/07/2018 | 6,99 | 7,06 | 6,85 | 6,92 | -0,72% | 3,00% | 81.200 |
| 30/07/2018 | 7,10 | 7,38 | 6,87 | 6,97 | -2,38% | 7,18% | 126.700 |
| 27/07/2018 | 7,27 | 7,68 | 7,01 | 7,14 | -1,65% | 9,26% | 61.900 |
| 26/07/2018 | 7,10 | 7,39 | 6,93 | 7,26 | +1,54% | 6,48% | 385.000 |
| 25/07/2018 | 7,19 | 7,35 | 7,09 | 7,15 | -0,69% | 3,62% | 129.800 |
| 24/07/2018 | 7,71 | 7,90 | 7,08 | 7,20 | -7,10% | 10,64% | 121.200 |
| 23/07/2018 | 7,89 | 7,98 | 7,61 | 7,75 | -1,77% | 4,68% | 96.200 |
| 20/07/2018 | 7,90 | 8,07 | 7,73 | 7,89 | -0,38% | 4,27% | 77.300 |
| 19/07/2018 | 7,81 | 8,00 | 7,80 | 7,92 | +1,28% | 2,56% | 52.400 |
| 18/07/2018 | 8,00 | 8,00 | 7,69 | 7,82 | -0,64% | 3,88% | 125.000 |
| 17/07/2018 | 7,57 | 7,96 | 7,51 | 7,87 | +4,52% | 5,94% | 95.200 |
| 16/07/2018 | 7,47 | 7,83 | 7,27 | 7,53 | +1,07% | 7,50% | 146.100 |
| 13/07/2018 | 7,43 | 7,55 | 7,06 | 7,45 | +0,27% | 6,59% | 82.900 |
| 12/07/2018 | 7,50 | 7,56 | 7,21 | 7,43 | -0,54% | 4,67% | 127.600 |
| 11/07/2018 | 7,54 | 7,79 | 7,26 | 7,47 | -1,45% | 7,03% | 128.300 |
| 10/07/2018 | 7,12 | 7,69 | 7,09 | 7,58 | +6,91% | 8,43% | 158.800 |
| 09/07/2018 | 7,01 | 7,13 | 6,87 | 7,09 | +1,43% | 3,71% | 123.700 |
| 06/07/2018 | 7,02 | 7,10 | 6,94 | 6,99 | -0,29% | 2,28% | 100.400 |
| 05/07/2018 | 7,14 | 7,16 | 6,90 | 7,01 | -1,68% | 3,64% | 170.200 |
| 03/07/2018 | 6,77 | 7,24 | 6,65 | 7,13 | +4,55% | 8,71% | 183.700 |
| 02/07/2018 | 6,69 | 6,82 | 6,57 | 6,82 | +1,49% | 3,74% | 152.000 |
| 29/06/2018 | 6,75 | 7,06 | 6,64 | 6,72 | +0,00% | 6,22% | 448.300 |
| 28/06/2018 | 6,76 | 7,00 | 6,64 | 6,72 | -0,44% | 5,33% | 256.700 |
| 27/06/2018 | 7,16 | 7,20 | 6,69 | 6,75 | -5,86% | 7,12% | 232.600 |